Key facts
- This page summarizes Robert Dee Etherington's Form 4 filing for Clene Inc. (CLNN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jul 2021, 09:19.
Robert Dee Etherington - 30 Jun 2021 Form 4 Insider Report for Clene Inc. (CLNN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CLNN
- Reported as of
- 30 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2021, 09:19:39 UTC
- Next SEC filing
- 04 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jerry Miraglia POA
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Dee Etherington filed Form 4 for Clene Inc. (CLNN) on 01 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLNN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +80,076
- Change %
- Price
- $0.000000
- Shares after
- 80,076
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
CLNN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,717
- Date
- 30 Jun 2021
- Ownership
- By LLC
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022.
Footnote F2
The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.